FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jing Jie Yu

Research Profile

Chemicals & Drugs

Disorders

Physiology

Anatomy

Tumor Cells, Cultured

Co-author Network

Publications

TOP 3
Yi Guo; Michael D Mueller; William Petros; Eddie Reed; Scot C Remick; Pingfu Fu; Honglan Zhu; Jing Jie Yu
Correlations among ERCC1, XPB, UBE2I, EGF, TAL2 and ILF3 revealed by gene signatures of histological subtypes of patients with epithelial ovarian cancer.
Xiaobing Liang; Michael D Mueller; William Douglas Figg; Antonio Tito Fojo; Yi Guo; Jing Jie Yu
The Role of Wild-Type p53 in Cisplatin-Induced Chk2 Phosphorylation and the Inhibition of Platinum Resistance with a Chk2 Inhibitor.
Jing Jie Yu; Guo-Wei Gu; Giovanni Esposito; Massimiliano Fabbricino; Shao-Po Wang; Li-Ping Sun
Determination of textile dyeing wastewater COD components by comparison with respirometry and full-scale data.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jing Jie Yu (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Yi Guo; Michael D Mueller; William Petros; Eddie Reed; Scot C Remick; Pingfu Fu; Honglan Zhu; Jing Jie Yu
Correlations among ERCC1, XPB, UBE2I, EGF, TAL2 and ILF3 revealed by gene signatures of histological subtypes of patients with epithelial ovarian cancer.
Oncology reports 2012;27(1):286-92.
2011: Xiaobing Liang; Michael D Mueller; William Douglas Figg; Antonio Tito Fojo; Yi Guo; Jing Jie Yu
The Role of Wild-Type p53 in Cisplatin-Induced Chk2 Phosphorylation and the Inhibition of Platinum Resistance with a Chk2 Inhibitor.
Chemotherapy research and practice 2011;2011():715469.
2010: Jing Jie Yu; Guo-Wei Gu; Giovanni Esposito; Massimiliano Fabbricino; Shao-Po Wang; Li-Ping Sun
Determination of textile dyeing wastewater COD components by comparison with respirometry and full-scale data.
Environmental technology 2010;31(11):1191-201.
2010: David A Clump; Jing Jie Yu; Youngjin Cho; Rui Gao; John Jett; Henry Zot; Jess M Cunnick; Brandi Snyder; Anne C Clump; Melissa Dodrill; Peter Gannett; James E Coad; Robert Shurina; W Douglas Figg; Eddie Reed; Daniel C Flynn
A Polymorphic Variant of AFAP-110 Enhances cSrc Activity.
Translational oncology 2010;3(4):276-85.
2010: Jing Jie Yu; Pingfu Fu; John J Pink; Dawn Dawson; Jay Wasman; Jackson Orem; Walter O Mwanda; Honglan Zhu; Xiaobing Liang; Yi Guo; William P Petros; Ronald T Mitsuyasu; Henry Wabinga; Scot C Remick
HPV infection and EGFR activation/alteration in HIV-infected East African patients with conjunctival carcinoma.
PloS one 2010;5(5):e10477.
2007: Jing Jie Yu; Daniel C Flynn
EGFR artifactual mutations associated with two DNA sequencers.
BioTechniques 2007;42(1):41.
2006: Xiaobing Liang; Eddie Reed; Jing Jie Yu
Protein phosphatase 2A interacts with Chk2 and regulates phosphorylation at Thr-68 after cisplatin treatment of human ovarian cancer cells.
International journal of molecular medicine 2006;17(5):703-8.
2006: Yongping You; Peiyu Pu; Qiang Huang; Zhibo Xia; Chunyan Wang; Guangxiu Wang; Chunzhao Yu; Jing Jie Yu; Eddie Reed; Qingdi Q Li
Antisense telomerase RNA inhibits the growth of human glioma cells in vitro and in vivo.
International journal of oncology 2006;28(5):1225-32.
2006: Qing-Wu Yan; Eddie Reed; Xiao-Song Zhong; Keith Thornton; Yi Guo; Jing Jie Yu
MZF1 possesses a repressively regulatory function in ERCC1 expression.
Biochemical pharmacology 2006;71(6):761-71.
2004: Ramin Altaha; Xiaobing Liang; Jing Jie Yu; Eddie Reed
Excision repair cross complementing-group 1: gene expression and platinum resistance.
International journal of molecular medicine 2004;14(6):959-70.
2004: Tiyuan Li; Yuping Song; Xiaobing Liang; Ying Guo; Eddie Reed; Jing Jie Yu
Confirmation of 42-bp deletion within the ERCC1 5' UTR.
International journal of oncology 2004;25(4):1105-11.
2004: Manasses K Yunmbam; Yi Guo; Michael R Miller; Jing Jie Yu
Combinatorial treatment of ovarian cancer cells with harringtonine and cisplatin results in increased cisplatin-DNA adducts.
Oncology reports 2004;11(4):833-8.
2003: Eddie Reed; Jing Jie Yu; Antony Davies; James Gannon; Steven L Armentrout
Clear cell tumors have higher mRNA levels of ERCC1 and XPB than other histological types of epithelial ovarian cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(14):5299-305.
2001: Jing Jie Yu; K Thornton; Y Guo; H Kotz; Eddie Reed
An ERCC1 splicing variant involving the 5'-UTR of the mRNA may have a transcriptional modulatory function.
Oncogene 2001;20(52):7694-8.
2001: Manasses K Yunmbam; Qingdi Q Li; Edward G Mimnaugh; Ganesh L Kayastha; Jing Jie Yu; L N Jones; Len Neckers; Eddie Reed
Effect of the proteasome inhibitor ALLnL on cisplatin sensitivity in human ovarian tumor cells.
International journal of oncology 2001;19(4):741-8.
2001: Qingdi Q Li; Manasses K Yunmbam; X Zhong; Jing Jie Yu; Edward G Mimnaugh; Len Neckers; Eddie Reed
Lactacystin enhances cisplatin sensitivity in resistant human ovarian cancer cell lines via inhibition of DNA repair and ERCC-1 expression.
Cellular and molecular biology (Noisy-le-Grand, France) 2001;47 Online Pub():OL61-72.
2000: M Dabholkar; K Thornton; J Vionnet; F Bostick-Bruton; Jing Jie Yu; Eddie Reed
Increased mRNA levels of xeroderma pigmentosum complementation group B (XPB) and Cockayne's syndrome complementation group B (CSB) without increased mRNA levels of multidrug-resistance gene (MDR1) or metallothionein-II (MT-II) in platinum-resistant human ovarian cancer tissues.
Biochemical pharmacology 2000;60(11):1611-9.
2000: Eddie Reed; M Dabholkar; K Thornton; Carol Thompson; Jing Jie Yu; F Bostick-Bruton
Evidence for in the appearance of mRNAs of nucleotide excision repair genes, in human ovarian cancer tissues.
Oncology reports 2000;7(5):1123-8.
2000: Jing Jie Yu; A Bicher; Y K Ma; F Bostick-Bruton; Eddie Reed
Absence of evidence for allelic loss or allelic gain for ERCC1 or for XPD in human ovarian cancer cells and tissues.
Cancer letters 2000;151(2):127-32.
2000: Qingdi Q Li; Jing Jie Yu; C Mu; Manasses K Yunmbam; D Slavsky; C L Cross; F Bostick-Bruton; Eddie Reed
Association between the level of ERCC-1 expression and the repair of cisplatin-induced DNA damage in human ovarian cancer cells.
Anticancer research 2000;20(2A):645-52.
2000: Jing Jie Yu; K B Lee; C Mu; Qingdi Q Li; T V Abernathy; F Bostick-Bruton; Eddie Reed
Comparison of two human ovarian carcinoma cell lines (A2780/CP70 and MCAS) that are equally resistant to platinum, but differ at codon 118 of the ERCC1 gene.
International journal of oncology 2000;16(3):555-60.
1998: Qingdi Q Li; L Ding; Jing Jie Yu; C Mu; B Tsang; F Bostick-Bruton; Eddie Reed
Cisplatin and phorbol ester independently induce ERCC-1 protein in human ovarian carcinoma cells.
International journal of oncology 1998;13(5):987-92.
1998: Jing Jie Yu; C Mu; M Dabholkar; Y Guo; F Bostick-Bruton; Eddie Reed
Alternative splicing of ERCC1 and cisplatin-DNA adduct repair in human tumor cell lines.
International journal of molecular medicine 1998;1(3):617-20.
1997: Jing Jie Yu; C Mu; K B Lee; A Okamoto; E L Reed; F Bostick-Bruton; K C Mitchell; Eddie Reed
A nucleotide polymorphism in ERCC1 in human ovarian cancer cell lines and tumor tissues.
Mutation research 1997;382(1-2):13-20.
1996: M D Dabholkar; M S Berger; J A Vionnet; L Overton; Carol Thompson; F Bostick-Bruton; Jing Jie Yu; J R Silber; Eddie Reed
Comparative analyses of relative ERCC3 and ERCC6 mRNA levels in gliomas and adjacent non-neoplastic brain.
Molecular carcinogenesis 1996;17(1):1-7.
1995: M D Dabholkar; M S Berger; J A Vionnet; Charles E Egwuagu; J R Silber; Jing Jie Yu; Eddie Reed
Malignant and nonmalignant brain tissues differ in their messenger RNA expression patterns for ERCC1 and ERCC2.
Cancer research 1995;55(6):1261-6.
1995: Jing Jie Yu; T J Glynn; TF Pechacek; M W Manley; M D Mueller; G Geng; S Wang; Y Gao; W R Lynn
The role of physicians in combatting the growing health crisis of tobacco-induced death and disease in the People's Republic of China.
Promotion & education 1995;2(1):23-30, 58.
1994: M Dabholkar; J Vionnet; F Bostick-Bruton; Jing Jie Yu; Eddie Reed
Messenger RNA levels of XPAC and ERCC1 in ovarian cancer tissue correlate with response to platinum-based chemotherapy.
The Journal of clinical investigation 1994;94(2):703-8.
1990: Jing Jie Yu; M E Mattson; G M Boyd; M D Mueller; D R Shopland; TF Pechacek; J W Cullen
A comparison of smoking patterns in the People's Republic of China with the United States. An impending health catastrophe in the middle kingdom.
JAMA : the journal of the American Medical Association 1990;264(12):1575-9.
1990: Jing Jie Yu; M D Mueller
Smoking prevalence and control efforts in China: a brief report from the field.
Hygie 1990;9(1):22-3.